This biotech stock is set to nearly quadruple on the back of its advanced gene therapy products, says Cantor Fitzgerald.
This biotech stock is set to nearly quadruple on the back of its advanced gene therapy products, says Cantor Fitzgerald
Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Wall Street drifts as stocks continue to follow the bond market's leadWall Street is drifting in mixed trading, continuing a months-long run where it’s followed the cue of the bond market.
Sumber: latimes - 🏆 11. / 82 Baca lebih lajut »
Wall Street climbs as bond selloff eases, earnings lift moodU.S. stocks rose on Tuesday as a selloff in U.S. Treasuries eased, while upbeat forecasts from Verizon, Coca-Cola and others boosted optimism about corporate America's health in the face of slowing economy and higher inflation.
Sumber: Reuters - 🏆 2. / 97 Baca lebih lajut »
Wall Street climbs after profits at big companies top forecastsVerizon jumped 7% after saying it increased its number of broadband subscribers by 20% and earned more than analysts expected during the summer.
Sumber: latimes - 🏆 11. / 82 Baca lebih lajut »